News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
218 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4450)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (221)
2 (198)
3 (246)
4 (134)
5 (2)
6 (26)
7 (189)
8 (263)
9 (229)
10 (265)
11 (138)
12 (2)
13 (5)
14 (238)
15 (260)
16 (218)
17 (239)
18 (111)
19 (1)
20 (3)
21 (103)
22 (312)
23 (250)
24 (321)
25 (115)
26 (6)
27 (5)
28 (328)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
Business
TenSixteen Bio Plumbs Somatic Mosaicism for Source of Multiple Diseases
TenSixteen Bio recently came out of stealth mode with $40 million in funding to target somatic mosaicism – particularly clonal hematopoiesis of indeterminate potential (CHIP).
February 16, 2022
·
3 min read
·
Gail Dutton
Drug Development
Mirati KRAS Inhibitor Snags December Decision Date
The NDA acceptance is based on positive results from the KRYSTAL-1 trial, which looked into the effect of using 600mg BID of adagrasib in patients.
February 16, 2022
·
2 min read
·
Vanessa Doctor, RN
FDA
FDA Ad Com Comes Down Hard on Avenue’s IV Tramadol
The FDA committee voted 8 yes and 14 no. The decision now goes back to the OND to decide the FDDR on Avenue Therapeutics’ IV Tramadol.
February 16, 2022
·
3 min read
·
Mark Terry
Drug Development
Sage and Biogen, BMS Boast Positive Data in Depression, HCM
Sage and Biogen announced positive topline results from the Phase III study of zuranolone that showed a rapid reduction in depressive symptoms after three days.
February 16, 2022
·
4 min read
·
Alex Keown
Drug Development
Global Roundup: Genuv Adds AI to Aid Discovery of Alzheimer’s, ALS Therapies
Biopharma and life sciences companies from across the globe provide updates to their pipelines and businesses.
February 16, 2022
·
8 min read
·
Alex Keown
Drug Development
Infusion Clinics are Key to Preparing Psychedelics for the Healthcare System
Psychedelics therapies – serotonin 2 A receptor agonists – are trying to enter mainstream medicine for depression and as anti-inflammatory or neuroprotective treatments.
February 16, 2022
·
6 min read
·
Gail Dutton
Business
HOOKIPA Takes Charge of Gilead-partnered HIV Program
HOOKIPA Pharma Inc.’s shares have soared after stating it amended and restated a collaboration and license agreement with Gilead Sciences to develop immunotherapies against HIV.
February 16, 2022
·
3 min read
·
Hayley Shasteen
Woman “Cured” of HIV with Umbilical Cord Blood Transplant
Dr. Yvonne Bryson presented the case of an American woman who was apparently cured of HIV after a new transplant procedure that leverages donated umbilical cord blood.
February 16, 2022
·
3 min read
·
Mark Terry
Business
Moderna Expands Asian Presence with Four New Subsidiaries
Moderna announced plans to expand in Asia with the opening of four new subsidiaries in Malaysia, Taiwan, Singapore and Hong Kong.
February 16, 2022
·
3 min read
·
Alex Keown
Policy
COVID-19 Update: Does Omicron Fading Mark the Pandemic’s Final Stages?
With the Omicron surge waning, at least in the U.S., there is speculation that the COVID-19 pandemic may be in its end stages. Some experts, however, warn that this could be premature.
February 16, 2022
·
6 min read
·
Mark Terry
1 of 22
Next